Trial Profile
A Phase II Open Label Trial to Investigate the Effect of Schistosoma Mansoni (Sm) Infection on the Immunogenicity of a Candidate TB Vaccine, MVA85A, in BCG-vaccinated African Adolescents
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Apr 2021
Price :
$35
*
At a glance
- Drugs MVA 85A (Primary)
- Indications Tuberculosis
- Focus Pharmacodynamics
- 29 Jan 2015 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
- 29 Jul 2014 New trial record